Top 5 Up And Coming Companies To Own For 2014

The auto industry is cyclical, which means that in bad times even the best companies cannot avoid declines in revenues. Two years ago, the earthquake in Japan disrupted production at automakers based in that country as well as their operations abroad. Today, a weak dollar and/or a slowly recovering in global demand for light vehicles could create a difficult environment for these companies.

The S&P Automobile Manufacturers Index increased 30.03% year to date. And as of the second quarter of 2013, J.D. Power and Associates and LMC Automotive estimated that global new light vehicle sales would increase 2.9% in 2013. With this positive outlook, let's take a look at two companies in this highly cyclical industry.

Toyota Motor Corporation (TM) the Japan-based corporation is now again the leading automaker in the world in terms of sales and production after the loss in reputation due to a series of safety recalls. It seems that the natural disasters in Japan and Thailand in 2011 were forgotten for the company. Considering total revenue in fiscal 2013, the three main segments were automotives (92.4% of revenue), financial services (5.2%) and others (2.4%).

Top Solar Stocks To Invest In Right Now: PLX Technology Inc.(PLXT)

PLX Technology, Inc. designs, develops, manufactures, and sells semiconductor devices worldwide. It offers semiconductor devices, such as PCI express switches that allow aggregation of multi-channel Ethernet, fiber channel, graphics, and SAS cards to the host; PCI express bridges, which allow devices with other standards to be used in systems that need to interoperate with PCI express; and 10G Ethernet over copper PHY devices that provide a seamless migration from the slower connections to the faster ones. The company?s products also include direct attached storage products, which allow external storage to connect to a PC through USB connection; network attached storage products that provide storage to a local area network; PCI bridges consisting of general purpose bridges that translate and extend the PCI bus; and universal serial bus (USB) interface chips, which are used by computer peripherals and consumer products to interoperate through an external cabled connection. Its semiconductor devices accelerate and manage the transfer of data in microprocessor-based systems, including networking and telecommunications, enterprise storage, servers, personal computers (PCs), PC peripherals, consumer electronics, imaging, and industrial products. The company markets its products through direct and indirect sales force, manufacturers, and distributors to electronics manufacturers. PLX Technology, Inc. was founded in 1986 and is headquartered in Sunnyvale, California.

Advisors' Opinion:

• [By Seth Jayson]

  PLX Technology (Nasdaq: PLXT  ) reported earnings on April 22. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q1), PLX Technology met expectations on revenues and beat expectations on earnings per share.

Top 5 Up And Coming Companies To Own For 2014: Rouse Properties Inc (RSE)

Rouse Properties, Inc. (Rouse), incorporated on August 10, 2011, is a real estate investment trust (REIT) company. Rouse is engaged in the operation, development and management of retail rental property. The Company�� portfolio consists of 30 regional malls in 19 states totaling over 21 million square feet of retail and ancillary space. The Company is a regional mall owner in the United State. It manages all of its properties, performing the day-to-day functions, operations, leasing, maintenance, marketing and promotional services. Its malls are anchored by operators across the retail spectrum. The Company�� regional malls include Sikes Senter Mall, Valley Hills Mall, Bayshore Mall and The Boulevard Mall. Its portfolio also includes regional malls that have growth through lease-up, repositioning and redevelopment. Rouse is a wholly owned subsidiary of GGP Limited Partnership (GGPLP), which is majority owned by General Growth Properties, Inc. (GGP). In February 2012, the Company purchased Grand Traverse Mall in Traverse City. In January 2013, the Company acquired the Mall at Turtle Creek and an adjacent shopping center, Turtle Creek Crossing. In July 2013, the Company announced the acquisition of Greenville Mall, in Greenville, North Carolina. In December 2013, the Company acquired Chesterfield Towne Center, in Richmond, Virginia, and the Centre at Salisbury, in Salisbury, Maryland.

The operators across the retail spectrum, including departments stores, such as Macy's, JC Penney, Sears, Dillard's, Walmart and Target; mall shop tenants, such as Hollister, Victoria's Secret, Bath & Body Works, Aeropostale, American Eagle, Children's Place, Gap/Old Navy, Footlocker, Maurices and Forever 21; restaurants ranging from food court, such as Sarku Japan, Panda Express and Chick Fil A; casual chains, such as Chipotle, Panera Bread and Starbucks, and sit down restaurants, including On The Border, Buffalo Wild Wings, Red Robin and multiple Darden concepts.

Advisors' Opinion:

• [By Mike Arnold]

  Brookfield's public assets include a 21% stake (and potentially more given certain warrants held by Brookfield) in General Growth Properties (GGP), a 51% stake in Brookfield Office Properties (BPO), a 36% stake (again, more if certain warrants are exercised) in Rouse Properties (RSE) and 21% stake in Canary Wharf Group Plc, which is majority owned by Songbird Estates Plc (SBEPF.PK).

Top 5 Up And Coming Companies To Own For 2014: ProShares Short FTSE Xinhua China 25 (YXI)

ProShares Short FTSE China 25 (the Fund) is an exchange-traded fund. The Fund seeks daily investment results that correspond to the inverse (opposite) of the daily performance of the FTSE/Xinhua China 25 Index (the Index). The Index consists of 25 of the largest and most liquid Chinese stocks listed on the Hong Kong Stock Exchange. This free float adjusted Index caps the weight of any of constituent stock at 10% to ensure broad representation of the Chinese economy. The Fund seeks investment results for a single day only, not for longer periods. The Index is compiled and calculated by FTSE International Limited (FTSE) on behalf of FTSE/Xinhua Index Limited (FXI). The Fund will typically concentrate its investments in issuers of one or more particular industries to the same extent that its underlying Index is so concentrated. The Fund�� investment advisor is ProShare Advisors LLC. Advisors' Opinion:

• [By pamatlarge]

  Three short ETFs are designed to profit from China�� economic downward slide. The ProShares Short FTSE China 25 (YXI), an unleveraged ETF, holds shares in iShares FTSE China Large-Cap (FXI) swaps. Investors looking to magnify their returns can choose from two leveraged short ETFs: ProShares Ultra Short FTSE China 25 (FXP) and Direxion Daily China Bear 3x Shares (YANG). Both ProShares Ultra Short and Direxion Daily hold shares that increase in value three times faster than an unleveraged ETF. The downside is that the per share price of these leveraged ETFs also drops three times faster.

Top 5 Up And Coming Companies To Own For 2014: Synergy Pharmaceuticals Inc (SGYP)

Synergy Pharmaceuticals, Inc., incorporated on February 11, 1992, is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company�� lead product candidate is plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, to treat GI disorders, primarily chronic constipation (CC), and constipation-predominant-irritable bowel syndrome (IBS-C). It is also developing SP-333, the second generation GC-C receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis (UC). The Company�� active pharmaceutical ingredients (APIs) and the final formulated drug products are manufactured for it by third party contractors.

As of December 31, 2011, the Company was developing plecanatide, a synthetic hexadecapeptide designed to mimic the actions of the GI hormone uroguanylin, for the treatment of CC and IBS-C. Plecanatide is an agonist of GC-C receptor. As of December 31, 2011, the Company was dosing patients in an 800-patient Phase II/III clinical trial of plecanatide to treat. It is also developing a second generation GC-C receptor analog, SP-333, which is in pre-clinical development for the treatment of gastrointestinal inflammatory diseases. SP-333 is a synthetic analog of uroguanylin, a natriuretic hormone.

The Company competes with Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.

Advisors' Opinion:

• [By Sean Williams]

  Finally, Synergy Pharmaceuticals (NASDAQ: SGYP  ) may have had the wildest week of them all. Synergy's share price spiked 16% on Tuesday as an analyst at Cantor Fitzgerald raised her peak sales estimate for plecanatide, the company's midstage drug for chronic idiopathic constipation and irritable bowel syndrome with constipation, to $1.58 billion from $1.05 billion, as clinical data has been stronger than expected. However, the company didn't return the favor to shareholders by -- the very next day, mind you ��announcing a secondary offering of 16.375 million shares. The downside of clinical-stage companies is the always apparent risk of dilution. Shares have lost 25% since their Tuesday close.

• [By Monica Gerson]

  Breaking news

  Time Warner Cable (NYSE: TWC) reported a drop in its third-quarter profit. Time Warner Cable's quarterly profit fell to $532 million, or $1.84 per share, from $808 million, or $2.60 per share, in the year-ago period. To read the full news, click here. Synergy Pharmaceuticals (NASDAQ: SGYP) today announced the start of a phase 2 clinical trial to evaluate the safety and efficacy of SP-333, its second-generation GC-C agonist and once-daily oral treatment, in adult patients with opioid-induced constipation (OIC). To read the full news, click here. Cigna (NYSE: CI) reported a 19% rise in its third-quarter earnings and lifted its full-year earnings outlook. To read the full news, click here. Charm Communications (NASDAQ: CHRM) announced today that the special committee of the Company's board of directors, consisting of independent directors Mr. Zhan Wang, Mr. Andrew J. Rickards and Mr. Gang Chen, has retained China Renaissance Securities (Hong Kong) Limited as its financial advisor and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP as its legal advisor. To read the full news, click here.

  Posted-In: Bank of America US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets